Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Mar 15;10(3):e05573.
doi: 10.1002/ccr3.5573. eCollection 2022 Mar.

Complement inhibitor eculizumab in thrombotic microangiopathy: Single-center case series

Monika Vitkauskaitė  1 , Artūras Vinikovas  1   2 , Marius Miglinas  1   2 , Laurynas Rimševičius  1   2 , Agnė Čerkauskaitė  1   2 , Ernesta Mačionienė  1   2 , Eglė Ašakienė  1   2
Affiliations
Case Reports

Complement inhibitor eculizumab in thrombotic microangiopathy: Single-center case series

Monika Vitkauskaitė et al. Clin Case Rep. .

Abstract

Our case series showed that eculizumab is efficacious and safe in treating thrombotic microangiopathy, as well as it has positive effects on quality of life. Further extensive studies are required to develop unified treatment guidelines.

Keywords: atypical hemolytic uremic syndrome; complement; eculizumab; nephrology; thrombotic microangiopathy.

PubMed Disclaimer

Conflict of interest statement

None.

Similar articles

See all similar articles

References

    1. Raina R, Krishnappa V, Blaha T, et al. Atypical hemolytic‐uremic syndrome: an update on pathophysiology, diagnosis, and treatment. Ther Apher Dial. 2019;23(1):4‐21. - PubMed
    1. Sridharan M, Go RS, Willrich MAV. Atypical hemolytic uremic syndrome: review of clinical presentation, diagnosis and management. J Immunol Methods. 2018;461:15‐22. - PubMed
    1. Loirat C, Fakhouri F, Ariceta G, et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2016;31(1):15‐39. - PubMed
    1. Fakhouri F, Zuber J, Frémeaux‐Bacchi V, Loirat C. Haemolytic uraemic syndrome. Lancet. 2017;390(10095):681‐696. - PubMed
    1. Al‐Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN. Drug‐induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015;125(4):616‐618. - PMC - PubMed

Publication types

LinkOut - more resources